Author Archive for: ANevill

About ANevill

This author has not written his bio yet.
But we are proud to say that ANevill contributed 38 entries already.

Entries by ANevill

Advent Life Sciences Announces Close of Two New Funds Totalling $215 million

18 February 2021

Read full release

Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline

8 February 2021

Read full release

The Key to Playing Harmoniously at BIO-Europe Spring® Digital 2021

8 February 2021

Can it really be almost a whole year since BIO-Europe Spring® 2020 went digital? In Groundhog Day, Bill Murray had become a concert pianist by this point in the film, having relived the same day several hundred times over, but wisely spending a little time each day to practice the piano, so he could successfully […]

Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP-300 Immunotherapeutic Candidate for Chronic HBV Patients

1 February 2021

Read full release

X-Bolt Features in Largest Ever Hip Fracture Fixation Trial Publication

1 February 2021

Read full release

BC Platforms, RIKEN and the Finnish Institute for Health and Welfare (THL) collaborate on artificial intelligence approach to identify people most at risk of from COVID-19

26 January 2021

Read full release

Pneumagen Announces £2.5m fundraising to advance universal treatment for viral respiratory infections into the clinic this year

21 January 2021

Read full release

InVixa announces licensing deal with University of California, Davis for the commercialization of novel inhaled statins for the treatment of COVID-19

19 January 2021

Read full release